| 股票 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 强生 JNJ | 一般药品制造商 | 31.9 | 7.80 | 1.9% | 61% | 68% | 35% | 14% | 59% | 4.2% | +6% | +91% | +16% | +35% | +58% | 98% | 6633 |
| 艾伯维公司 ABBV | 一般药品制造商 | 72.4 | -76.35 | 2.6% | 191% | 70% | 15222% | 5% | 102% | 4.3% | +9% | -1% | +15% | +15% | +26% | 96% | 4532 |
| 默沙东 MRK | 一般药品制造商 | 120.3 | 8.85 | 2.2% | 269% | 75% | 37% | 18% | 62% | 5.4% | +1% | +7% | +27% | +45% | +85% | 96% | 3709 |
| 诺华制药 NVS | 一般药品制造商 | 24.2 | 7.32 | 3.0% | 72% | 76% | 31% | 11% | 58% | 6.0% | +10% | +17% | +8% | +20% | +28% | 97% | 3041 |
| 阿斯利康 AZN | 一般药品制造商 | 24.4 | 5.02 | 1.9% | 47% | 82% | 21% | 10% | 57% | 5.4% | +9% | +45% | -8% | -10% | +2% | 78% | 2523 |
| 安进 AMGN | 一般药品制造商 | 27.2 | 20.22 | 2.2% | 61% | 67% | 106% | 10% | 90% | 5.3% | +10% | +88% | +30% | +36% | +60% | 98% | 2364 |
| 诺和诺德 NVO | 一般药品制造商 | 11.4 | 6.05 | 3.8% | 44% | 81% | 61% | 24% | 64% | 4.0% | +20% | +14% | +10% | -4% | -10% | 76% | 2081 |
| 吉利德科学 GILD | 一般药品制造商 | -57.0 | 15.83 | 2.1% | — | 79% | 40% | 7% | 62% | 7.2% | +2% | +1673% | +25% | +24% | +34% | 97% | 1872 |
| 施贵宝 BMY | 一般药品制造商 | 14.7 | 6.12 | 3.8% | 55% | 71% | 40% | 8% | 79% | 9.4% | -0% | +179% | +22% | +28% | +50% | 97% | 1365 |
| 葛兰素史克 GSK | 一般药品制造商 | 15.7 | 4.19 | 3.6% | 56% | 72% | 38% | 17% | 74% | 11.1% | +12% | +129% | -2% | +4% | +29% | 83% | 1000 |
| Organon & Co OGN | 一般药品制造商 | 17.7 | 3.60 | 0.6% | 10% | 53% | 31% | 9% | 94% | 20.4% | -3% | -78% | +3% | +93% | +33% | 100% | 36 |
点表头排序。市值单位亿美元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。